liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Läkemedelsbiverkningar som kan uppkomma i munhålan: [Adverse drug reactions in the oral cavity]
Linköping University, Faculty of Medicine and Health Sciences. Region Östergötland, Center for Diagnostics, Department of Clinical Pharmacology. Linköping University, Department of Biomedical and Clinical Sciences, Division of Clinical Chemistry and Pharmacology.ORCID iD: 0000-0002-3364-5767
Kliniken för orofacial medicin, Mälarsjukhuset, Eskilstuna; Region Sörmland.
2024 (Swedish)In: Läkartidningen, ISSN 0023-7205, E-ISSN 1652-7518, Vol. 121, article id 23205Article in journal, Letter (Other academic) Published
Abstract [sv]

Många läkemedelsbiverkningar manifesterar sig i munhålan.

Biverkningar i munhålan är sällan livshotande, men kan ändå ha stor inverkan på patienters välbefinnande och livskvalitet.

Både läkare och tandläkare behöver kunna identifiera och reagera på biverkningar i munhålan och ibland samverka kring åtgärder och behandling av dessa.

Både läkare och tandläkare har en skyldighet att rapportera misstänkta läkemedelsbiverkningar till Läkemedelsverket, oavsett var förskrivningen skett.

Abstract [en]

Adverse drug reactions commonly occur in the oral cavity, and although these reactions are seldom life threatening, they may severely affect quality of life, as well as the nutritional status of the patient. Hyposalivation is often caused by antidepressants, antihistamines, and diuretics, and the risk increases with polypharmacy. A dry mouth may in turn lead to oral candidosis, which may also be caused by treatment with antibiotics, immunosuppressants or corticosteroids. Other possible adverse drug reactions that may be seen in the oral cavity include gingival hyperplasia, ulcerations, allergic mucosal reactions, changes in sensibility or taste, as well as discoloration of saliva and/or the oral mucosa. Drug-induced osteonecrosis of the jaw from bisphosphonates is also mentioned in this context. The risk of many adverse drug reactions in the mouth can be decreased by good oral hygiene, in combination with regular revisions of the patient's drug treatment. However, there is a risk that physicians do not examine the oral cavity, while dentists may not have complete information about the patient's drug treatment. A close collaboration between medical and dental health care is the key to reducing adverse drug reactions in the mouth.

Place, publisher, year, edition, pages
Läkartidningen Förlag AB , 2024. Vol. 121, article id 23205
National Category
Odontology
Identifiers
URN: urn:nbn:se:liu:diva-212772PubMedID: 38470273Scopus ID: 2-s2.0-8518779277OAI: oai:DiVA.org:liu-212772DiVA, id: diva2:1949020
Available from: 2025-04-01 Created: 2025-04-01 Last updated: 2025-06-26

Open Access in DiVA

No full text in DiVA

Other links

PubMedScopusLänk till artikel/Link to article

Authority records

Böttiger, Ylva

Search in DiVA

By author/editor
Böttiger, Ylva
By organisation
Faculty of Medicine and Health SciencesDepartment of Clinical PharmacologyDivision of Clinical Chemistry and Pharmacology
In the same journal
Läkartidningen
Odontology

Search outside of DiVA

GoogleGoogle Scholar

pubmed
urn-nbn

Altmetric score

pubmed
urn-nbn
Total: 60 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf